Yarger Wealth Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
8,782
+698
+9% +$81.7K 0.39% 52
2026
Q1
$972K Buy
8,084
+1,178
+17% +$136K 0.39% 49
2025
Q4
$727K Sell
6,906
-138
-2% -$13K 0.31% 56
2025
Q3
$591K Buy
7,044
+1,856
+36% +$153K 0.27% 61
2025
Q2
$411K Buy
5,188
+2,305
+80% +$183K 0.21% 69
2025
Q1
$259K Buy
2,883
+346
+14% +$32.3K 0.15% 78
2024
Q4
$252K Buy
+2,537
New +$262K 0.15% 76

Other funds holding MRK

Yarger Wealth Strategies's MRK Position: Q2 2026 in Review

Yarger Wealth Strategies increased its Merck (MRK) stake by 8.6% in Q2 2026, buying an estimated $81.7K and bringing the position to 8,782 shares worth $1.08M. The position accounts for 0.39% of the portfolio, ranked #52.

Yarger Wealth Strategies first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Yarger Wealth Strategies held 8,782 shares of Merck worth $1.08M as of Q2 2026.
  • Yarger Wealth Strategies bought 698 Merck shares in Q2 2026, an estimated $81.7K.
  • Merck made up 0.39% of Yarger Wealth Strategies's portfolio in Q2 2026, its #52 holding.
  • Yarger Wealth Strategies first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Yarger Wealth Strategies's 13F filing for Q2 2026, filed 14 Jul 2026.